Balancing Efficacy and Safety of an Anti-Dll4 Antibody Through Pharmacokinetic Modulation
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-15-1380
Full Text
Open PDFAbstract
Available in full text
Date
November 20, 2015
Authors
Publisher
American Association for Cancer Research (AACR)